The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allerg...

Detaylı Bibliyografya
Asıl Yazarlar:	Yaping Zhao, Rongrong Liu, Miaomiao Li, Pengfei Liu
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2022-12-01
Seri Bilgileri:	Heliyon
Konular:	Spleen tyrosine kinase (SYK) Liver diseases Small molecule inhibitor Therapy target
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S2405844022034181

Benzer Materyaller

The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
Yazar:: Eszter Káposztás, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
Yazar:: Nichola Cooper, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
Yazar:: Pankaj Kumar Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Activation of spleen tyrosine kinase (SYK) contributes to neuronal pyroptosis and cognitive impairment in diabetic mice via the NLRP3/Caspase-1/GSDMD signaling pathway
Yazar:: Chenglong Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence [version 3; peer review: 2 approved]
Yazar:: Carl Laflamme, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice
Yazar:: Dániel Csete, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
Yazar:: Mohan Li, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
Yazar:: Ryunosuke Muro, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Yazar:: Christopher W. Pohlmeyer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
Yazar:: Bright Obeng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
Yazar:: Kata P. Szilveszter, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis
Yazar:: Mariano Prado Acosta, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
Yazar:: Hyang‑Hee Seo, ve diğerleri

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <italic toggle="yes">Candida</italic> Species
Yazar:: Paige E. Negoro, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
Yazar:: Yaqi Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease
Yazar:: Wenbin Gong, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
Yazar:: Qian Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers
Yazar:: Akram I Alwithenani, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets
Yazar:: Carol Dangelmaier, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
Yazar:: Jing Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
Yazar:: Bingjie Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis
Yazar:: Fan Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

Development of SYK NanoBRET cellular target engagement assays for gain–of–function variants
Yazar:: Jacob L. Capener, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice
Yazar:: Maki Kitai, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
Yazar:: Yi-fan Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Tyrosine kinase targeting: A potential therapeutic strategy for diabetes
Yazar:: Mohammad Althubiti
Baskı/Yayın Bilgisi: (2022-01-01)

Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
Yazar:: Alex Hopke, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Yazar:: Soumitra Ghosh, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages
Yazar:: Zeina Dagher, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
Yazar:: Chen-Yu Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Yazar:: Xuejin Ou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
Yazar:: Halil Ibrahim Onder, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Receptor Tyrosine Kinase Signaling Involves <i>Echinococcus</i>–Host Intercommunication: A Potential Therapeutic Target in Hepatic Echinococcosis
Yazar:: Haijun Gao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
Yazar:: Qinlian Jiao, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
Yazar:: Sareshma Sudhesh Dev, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
Yazar:: D. Samuel Metibemu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Recent developments in receptor tyrosine kinases targeted anticancer therapy
Yazar:: Samir H. Raval, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin
Yazar:: Hadas Smadar, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Yazar:: Xu H, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
Yazar:: Ming Zeng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)